|
||||||||||
|
||||||||||
Home Page Make Us Your Home Page Discuss Your Medicine Medicines Submitted  Prescription Drug Forums Top 200 Prescription Drugs Drugs by Category Recent FDA Approvals November 2008 Health News Advertising & Contact Details About the Community Terms of Use & Privacy Medical Disclaimer Helpful Tools Health Insurance Quotes Find a Healthcare Provider Recent Searches (USA Pacific) 4:33:11 AM Folic Acid... 4:32:32 AM Hydroxyz Hcl... 4:31:26 AM Claricort... 4:28:42 AM Hydrocodone... 4:28:14 AM Pill Barr 555 490... 4:27:09 AM Darvocet V 5112... 4:24:23 AM Cyclovir... 4:23:15 AM Sertalin... 4:22:26 AM J 368... 4:20:36 AM Penicillin... 4:20:11 AM Zanadine... 4:20:06 AM Aranest... 4:18:04 AM Odine... 4:17:52 AM Azithromycin... 4:17:05 AM Gain... 4:17:01 AM Adine... 4:16:52 AM Sanadine... 4:16:36 AM Zonadine... 4:16:19 AM Sonadine... 4:16:17 AM Colotapin... |
KaletraActive Ingredient(s): Lopinavir + RitonavirFirst Approved by the FDA: September 15, 2000 Pharmaceutical Company: ABBOTT 
 Start a New Kaletra DiscussionKaletra Article SummaryLopinavir (abt-378) Is An Antiretroviral Of The Protease Inhibitor Class. It Is Marketed By Abbott As Kaletra (capsules) And Aluvia (non-refrigerated Tablets), Both Of Which Represent A Co-formulation With A Sub-therapeutic Dose Of Ritonavir, As A Component Of Combination Therapy To Treat Hiv/aids. The Kaletra Formulation Has Also Been Used Successfully As Monotherapy In Some Studies.[1] as Of 2006, Lopinavir/ritonavir Forms Part Of The Preferred Combination For First-line Therapy Recommended By ... View Full Article for KaletraArticle May Include Instructions, Side Effects, Interactions, Etc. Article Opens in a New Window. This article is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License) | http://en.wikipedia.org/wiki/Kaletra Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to KaletraCapsule 133.3mg + 33.3mg Solution 80mg/ml + 20mg/ml Tablet 100mg + 25mg, 200mg + 50mg Related Drug Listing(s):Other Drugs Containing Lopinavir or Ritonavir or a Similar Compund: Related Search Results for KaletraWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Kaletra Text Link HTML Code: Related: manufacturer about report treatment community Kaletra, Kaletra medicine medicine help review, medication Kaletra, learn Kaletra, Kaletra warnings picture withdrawal types trials, medication Kaletra, research comparison educate FDA pharmaceutical Kaletra, Kaletra national monograph, Kaletra alternative consultation consultation pill, Kaletra dictionary biotech about. Lopinavir + Ritonavir locate what is biotech identify, Lopinavir + Ritonavir plan label withdrawal, Lopinavir + Ritonavir find forums foreign school, research about precautions learn help Lopinavir + Ritonavir, Lopinavir + Ritonavir institute, dose community pharmacist clinical forums Lopinavir + Ritonavir.
Return to Top This information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2008 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Kaletra.asp Last Modified November 9 2008 |
|||||||||
Pfizer, Inc. | GlaxoSmithKline | Merck | AstraZeneca | Johnson & Johnson | Aventis | Bristol-Myers Squibb | Novartis | Pharmacia (Pfizer) Wyeth | Lilly | Abbott | Roche | Schering-Plough | Takeda | Sanofi-Synthelabo | Boehringer-Ingelheim | Bayer | Schering AG | Sankyo |
||||||||||
